Table 2.
Pathogen Type | Clinical Forms of NIs | MDR Bacteria (n=188) | Total (n=389) | |||||
---|---|---|---|---|---|---|---|---|
RTI (n=219) | BSI (n=87) | UTI (n=24) | IAI (n=24) | SSI (n=21) | Others (n=14) | |||
Gram-negative bacteria | ||||||||
Acinetobacter baumannii, No. (%) | 89 (40.6) | 17 (19.5) | 1 (4.2) | 6 (25.0) | 8 (38.1) | 2 (14.3) | 114 (60.6) | 123 (31.6) |
Pseudomonas aeruginosa, No. (%) | 39 (17.8) | 4 (4.6) | 5 (20.8) | 2 (8.3) | 2 (9.5) | – | 10 (5.3) | 52 (13.4) |
Escherichia coli, No. (%) | 12 (5.5) | 5 (5.7) | 4 (16.7) | 3 (12.5) | 3 (14.3) | 5 (35.7) | 11 (5.9) | 32 (8.2) |
Klebsiella pneumoniae, No. (%) | 15 (6.8) | 3 (3.4) | 2 (8.3) | 3 (12.5) | 2 (9.5) | 2 (14.3) | 7 (3.7) | 27 (6.9) |
Stenotrophomonas maltophilia, No. (%) | 13 (5.9) | 3 (3.4) | – | 1 (4.2) | – | – | – | 17 (4.4) |
Miscellaneous Gram-negative bacilli, No. (%) | 22 (10.0) | 9 (10.3) | 3 (12.5) | 2 (8.3) | 2 (9.5) | 4 (28.6) | 7 (3.7) | 42 (10.8) |
Gram-positive bacteria | ||||||||
Coagulase-negative staphylococci, No. (%) | – | 29 (33.3) | 2 (8.3) | – | – | – | 27 (14.4) | 31 (8.0) |
Enterococcus faecium, No. (%) | 2 (0.9) | 5 (5.7) | 6 (25.0) | 5 (20.8) | 2 (9.5) | 1 (7.1) | 2 (1.1) | 21 (5.4) |
Corynebacterium striatum, No. (%) | 9 (4.1) | 2 (2.3) | – | – | – | – | 1 (0.5) | 11 (2.8) |
Staphylococcus aureus, No. (%) | 6 (2.7) | – | – | – | 1 (4.8) | – | 5 (2.7) | 7 (1.8) |
Miscellaneous Gram–positive cocci, No. (%) | 1 (0.5) | 5 (5.7) | – | 1 (4.2) | 1 (4.8) | – | 4 (2.1) | 8 (2.1) |
Fungi | ||||||||
Candida albicans, No. (%) | 5 (2.3) | 4 (4.6) | 1 (4.2) | 1 (4.2) | – | – | – | 11 (2.8) |
Non-albicans Candida spp., No. (%) | 6 (2.7) | 1 (1.1) | – | – | – | – | – | 7 (1.8) |
Abbreviations: MDR, Multi-drug resistant; NIs, Nosocomial infections; RTI, Respiratory tract infection; BSI, Bloodstream infection; UTI, Urinary tract infection; IAI, Intra-abdominal infection; SSI, Surgical site infection.